GI Oncology Now

The leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Dr. Timothy Brown: Advancing GI Cancer Treatment Through Research Excellence

Dr. Timothy Brown, a leading gastrointestinal oncologist at UT Southwestern Medical Center, discusses his career path from Virginia Tech to Penn State and beyond in an interview with GI Oncology Now, highlighting the influential mentors and pivotal experiences that shaped his career in GI oncology.

Dr. Brown speaks about some of the innovative clinical trials underway at UT Southwestern, the challenges of balancing clinical practice with research, and his vision for the future of GI cancer treatment.

Latest News

Survival Outcomes of Neoadjuvant mFOLFIRINOX for Resectable PDAC

Michael Cecchini, MDPancreatic Cancer | July 26, 2024

Dr. Cecchini explains how ctDNA was used in this study as well as which methods were used for analyzing ctDNA levels.

Examining the Lifetime Risk of Gastric Cancer in Patients With CDH1 Gene Variants

Grace-Ann Fasaye, ScM, CGCGastric Cancer | July 25, 2024

Grace-Ann Fasaye discusses the elevated lifetime risk of gastric cancer in patients with CDH1 gene variants.

Potential of Interpretable AI to Determine Treatment With Imatinib for GISTs

Katy MarshallGIST | July 24, 2024

The AI model used predictors of recurrence and duration imatinib treatment to determine recurrence risk.

FIGHT-202: Analyzing the Effects of Pemigatinib in Patients With Cholangiocarcinoma

Katy MarshallBile Duct Cancer | July 22, 2024

Participants received pemigatinib 13.5 mg once per day for 21-day cycles with 2 weeks on and 1 week off.

TAS102 and Regorafenib Provide Synergistic Activity Against GI Cancers

Emily MenendezGI Cancer | July 19, 2024

Researchers examined TAS102 with regorafenib to determine if the combination is active in CRC and other GI malignancies.

TGF-β Signaling Blockade Necessary for Anti-HCC Activity Via NK Cells

Emily MenendezHepatocellular Carcinoma | July 18, 2024

While immunotherapy paired with VEGF inhibitors are considered first-line options, they only provide modest efficacy.

Stiripentol May Increase Chemotherapy Efficacy in Gastric Cancer

Katy MarshallGastric Cancer | July 18, 2024

Researchers reported that a buildup of lactate was most notable in chemotherapy-resistant cancer tissues.

Potential Benefits of Serum Fusion Transcripts in HCC

Jian-Hua Luo, MD, PhDHepatocellular Carcinoma | July 17, 2024

Dr. Luo describes the performance of the two-fusion gene + α-fetal protein logistic regression model.

Using Machine Learning Models to Diagnose, Monitor HCC

Jian-Hua Luo, MD, PhDHepatocellular Carcinoma | July 17, 2024

Dr. Luo explains the potential benefits of machine learning for patients with hepatocellular carcinoma.

Analyzing Atezolizumab, Bevacizumab as a First-Line Treatment for Patients With HCC

Katy MarshallUnresectable HCC | July 18, 2024

Median OS was 9.1 months for patients with CP-B7 and 4.7 months for those with CP-B8-C12.

Roundtable Discussions

Oncology Brothers Event Coverage

Advancements in Oncology: GI Cancer

GI Oncology Now has exclusive coverage of Advancement in Oncology: Today’s Data for Tomorrow’s Practice, the first event co-hosted by The Oncology Brothers and Mashup Media. Review the breakthrough data on gastrointestinal cancers presented at the event and insights from esteemed experts that bridge the gap between research and practice for community oncologists.

Conference Coverage

ASCO 2024: GI Oncology Now

The latest news and research updates in GI cancer treatment from the ASCO 2024 Annual Meeting

ASCO GI Symposium 2024

GI Oncology Now reviews education from ASCO GI 2024, featuring the latest advances in the field of GI cancer research.

International Society of Gastrointestinal Oncology 2023 Annual Meeting

GI Oncology Now reviews education from ISGIO 2023, featuring the latest advances in the field of GI cancer research.

Expert Interviews

Benjamin Weinberg, MD, FACPEditor | Associate Professor of Medicine at Lombardi Comprehensive Cancer Center

Zev Wainberg, MD, MScEditor | Co-Director of Gastrointestinal Oncology at the University of California, Los Angeles